Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Warsaw - Delayed Quote PLN

Selvita S.A. (SLV.WA)

33.00
+0.70
+(2.17%)
At close: April 25 at 5:00:00 PM GMT+2
Currency in PLN All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
342,007
342,007
346,720
360,680
310,921
Cost of Revenue
74,190
74,190
71,158
68,065
59,665
Gross Profit
267,817
267,817
275,562
292,615
251,256
Operating Expense
268,305
268,305
258,813
252,690
225,171
Operating Income
-488
-488
16,749
39,925
26,085
Net Non Operating Interest Income Expense
-12,815
-12,815
-10,474
-4,804
-3,856
Pretax Income
-10,454
-10,454
67,203
35,103
21,068
Tax Provision
-4,356
-4,356
-2,675
6,811
2,846
Net Income Common Stockholders
-6,098
-6,098
69,878
30,309
14,899
Diluted NI Available to Com Stockholders
-6,098
-6,098
69,878
30,309
14,899
Basic EPS
-0.30
-0.30
3.80
1.70
0.80
Diluted EPS
-0.30
-0.30
3.80
1.70
0.80
Basic Average Shares
18,355.47
18,355.47
18,355.47
18,355.47
18,355.47
Diluted Average Shares
18,355.47
18,355.47
18,355.47
18,355.47
18,355.47
Total Operating Income as Reported
-487
-487
69,311
39,925
26,085
Total Expenses
342,495
342,495
329,971
320,755
284,836
Net Income from Continuing & Discontinued Operation
-6,098
-6,098
69,878
30,309
14,899
Normalized Income
-6,412.28
-6,412.28
70,558.40
25,993
14,899
Interest Income
17
17
512
4
14
Interest Expense
12,655
12,655
10,844
4,196
3,801
Net Interest Income
-12,815
-12,815
-10,474
-4,804
-3,856
EBIT
2,201
2,201
78,047
39,299
24,869
EBITDA
55,300
55,300
123,499
76,127
52,357
Reconciled Cost of Revenue
74,190
74,190
71,158
68,065
59,665
Reconciled Depreciation
53,099
53,099
45,452
36,828
27,488
Net Income from Continuing Operation Net Minority Interest
-6,098
-6,098
69,878
25,993
14,899
Total Unusual Items Excluding Goodwill
388
388
-840
--
-479.95
Total Unusual Items
388
388
-840
--
-479.95
Normalized EBITDA
54,912
54,912
124,339
76,127
52,357
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
73.72
73.72
-159.60
--
--
12/31/2021 - 10/17/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

300347.SZ Hangzhou Tigermed Consulting Co., Ltd
45.05
-0.97%
 
603127.SS Joinn Laboratories(China)Co.,Ltd.
15.54
+0.65%
 
IJF.MU Icon PLC
128.05
+2.56%
 
0RUG.IL bioMérieux S.A.
115.70
+1.58%
 
TN8.DE Thermo Fisher Scientific Inc.
372.95
+0.11%
 
ILU.F Illumina, Inc.
67.18
-0.80%
 
QIA.DE Qiagen N.V.
37.02
-1.57%
 
DAP.DE Danaher Corporation
172.68
+0.28%
 
DIA.WA Diagnostyka S.A.
152.00
+2.36%
 
DMTKQ DermTech, Inc.
0.0001
0.00%